Modern Innovations
-
Posted: September 09, 2024
The birthrate in the United States has hit a new record low, according to an analysis of 2023 birth certificate data published this past spring by the Centers for Disease Control and Prevention (CDC). Last year’s slowdown marks an end to the uptick in new babies that began during...
-
Posted: July 29, 2024
Scientists are continually seeking new weapons in the arms race against increasingly resistant bacteria. One of our oldest weapons, copper, may hold the key to curbing the rise of these superbugs...
-
Posted: March 04, 2024Categories: Modern Innovations, Featured Posts, Product Spotlights, Product Spotlights, Microbiology
The benefits of using chromogenic media include faster results, reliable visual detection and additional testing is possible directly from the media. Compared with the use of conventional culture media, this often results in cost savings from reduced labor time and reduced use of reagents as fewer biochemical and/or serological confirmation tests are required...
-
Posted: February 19, 2024
Learn how this innovative technology revolutionizes air sampling in various environments, ensuring precise and reliable results for microbiological analysis. Elevate your sampling experience with TRIO.BAS™ and stay ahead in quality assurance...
-
Posted: January 16, 2024Dive into the evolution of portable microbial air samplers in our latest blog! Explore the rich history and technological advancements, featuring an exclusive interview with the founders of Orum International. Uncover the journey of innovation in microbial air sampling. Read more for insights into the past, present, and future of this crucial technology...Read More
-
Posted: January 10, 2024Categories: Modern Innovations, Clinical, Industry Insights, Case & Study Reviews, Health & Wellness, MicrobiologyComments: 1
Hepatitis C is the primary cause of liver cancer and the need for liver transplants among patients infected with the virus.
Infection is often the result of coming into contact with contaminated blood, usually through injected drug use, but also...
-
Posted: January 04, 2024
Carbapenem-resistant Enterobacterales or CRE, are a group of gram-negative bacteria that are resistant to “last line” antibiotics and are very challenging to treat. These microorganisms may confer their resistance via the production of a carbapenemase, an enzyme that inactivates carbapenem antibiotics.
The five most common types of carbapenemases are KPC,...
-
Posted: October 09, 2023
-
Posted: June 20, 2023
Maggots to the rescue? How Revolting!
The First World War was a huge tragedy for humanity, but it represented a source of significant progress for physicians to improve their knowledge in the treatment of lesions and wounds.
The most frequent causes of death at the time, surprisingly, were not related to gunshots or chemical warfare but, rather,...
-
Posted: December 06, 2022
With more than 1,000 potential microbes known to cause human disease, the differential diagnosis of pathogens can be complex and challenging.
Traditional microbial culture-based methods are the most common and readily available tests for identification, but the turnaround time can be long when organisms are difficult to culture or arduous...
-
Posted: October 28, 2022
-
Posted: October 14, 2022
Saving lives during WWII
Howard Walter Florey was a famed pathologist and pharmacologist from Australia known for being one of the first researchers to manufacture penicillin. Before his success with penicillin, Florey was on the hunt for a naturally occurring antibacterial...
-
Posted: June 09, 2022
Miracle in the Mucin... Discovered in 2004, Akkermansia muciniphila is a relative newcomer to microbiology. Akkermansia was named for the microbial ecologist Antoon Akkermans, and muciniphila meaning preferring mucin. This organism in the phylum Verrucomicrobia was the result of a study that used purified mucin as...
-
Posted: April 15, 2022
Genetic engineering can help preserve endangered species
Since 1978, Escherichia coli has been used in the development of synthetic “human” insulin (1). More recently, E. coli has become an essential part in the development of cancer drugs (2). Researchers at The Novo Nordisk Foundation Center for Biosustainability in...
-
Posted: March 21, 2022Categories: Modern Innovations, Clinical, Industry Insights, Public Health Alerts, Health & Wellness
As the COVID-19 pandemic moves into its third year, new treatment options to combat the coronavirus disease are being authorized by the U.S. Food and Drug Administration. In December, 2021, the FDA issued emergency use authorization (EUA) for two oral antiviral treatments for COVID-19, Molnupiravir and Paxlovid.(1,2)
This comes at a crucial time in the pandemic as new variants emerge and COVID-19...